This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Western University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,101,600
Bacterial Immunotherapy for Bladder Cancer
CIHR · 2025 · Nominated PI
- $50,000
COVID-19 Variant Supplement - Shutting down emerging Coronaviruses in humans now and in the future
CIHR · 2021 · Co-investigator
- $799,426
Development of Molecular Imaging Tools to Monitor the Fate of an Off-The-Shelf Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Immunotherapy
CIHR · 2021 · Co-investigator
Bacterial Immunotherapy for Bladder Cancer
Principal investigators: Haeryfar, S.M. Mansour
Keywords: Bacille Calmette-Guérin; Bladder Cancer; Cancer Immunology; Cytokines; Immunotherapy; Innate-Like T Lymphocytes; Mait Cells; Mhc-Related Protein 1; Riboflavin; Tumor Microenvironments
COVID-19 Variant Supplement - Shutting down emerging Coronaviruses in humans now and in the future
Principal investigators: Barr, Stephen D; Arts, Eric J; Kang, Chil Yong; Troyer, Ryan
Keywords: Coronavirus; Immunity; Infection; Mouse Model; Pathogenesis; Reverse Genetics; Vaccine; Viral Replication
Development of Molecular Imaging Tools to Monitor the Fate of an Off-The-Shelf Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Immunotherapy
Principal investigators: Ronald, John A
Keywords: Cancer Immunotherapy; Chimeric Antigen Receptor; Human Epidermal Receptor-2 (Her2); Magnetic Resonance Imaging; Molecular Imaging; Natural Killer Cells; Ovarian Cancer; Positron Emission Tomography; Reporter Gene
Shutting down emerging Coronaviruses in humans now and in the future
Principal investigators: Barr, Stephen D; Arts, Eric J; Kang, Chil Yong; Troyer, Ryan
Keywords: Coronavirus; Immunity; Infection; Mouse Model; Pathogenesis; Reverse Genetics; Vaccine; Viral Replication
Sex as a Biological Variable Supplement - Shutting down emerging Coronaviruses in humans now and in the future
Principal investigators: Barr, Stephen D; Arts, Eric J; Kang, Chil Yong; Troyer, Ryan
Keywords: Coronavirus; Immunity; Infection; Mouse Model; Pathogenesis; Reverse Genetics; Vaccine; Viral Replication
Mobilizing the Antiviral Capacities of MAIT Cells to Combat COVID-19: From Fundamental Immunology to Vaccine Optimization and Immunotherapy
Principal investigators: Haeryfar, S.M. Mansour
Keywords: Covid-19; Critical Care; Immunity And Immunopathology; Immunotherapy; Infection; Inflammation; Mait Cells; Mouse Models; Sars-Cov-2; Vaccination
Development of Molecular Imaging Tools to Monitor the Fate of an Off-The-Shelf Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Immunotherapy for Breast Cancer
Principal investigators: Ronald, John A
Keywords: Breast Cancer; Cancer Immunotherapy; Chimeric Antigen Receptor; Magnetic Resonance Imaging; Molecular Imaging; Natural Killer (Nk) Cells; Positron Emission Tomography; Reporter Gene
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
Principal investigators: Haeryfar, SMMansour
An x-ray irradiator cabinet for live cell irradiation
Principal investigators: SchildPoulter, Caroline
Functional Roles and Therapeutic Potentials of Invariant NKT Cells in Sepsis
Principal investigators: Haeryfar, S.M. Mansour
Keywords: Anergy; Cytokines; Immune Regulation; Immunology; Immunosuppression; Immunotherapy; Infection; Inflammation; Sepsis; T Lymphocytes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.